Výsledky vyhľadávania - "Jung, Young Kul"

  1. 1

    Hepatic resection compared to chemoembolization in intermediate‐ to advanced‐stage hepatocellular carcinoma: A meta‐analysis of high‐quality studies Autor Hyun, Myung Han, Lee, Young‐Sun, Kim, Ji Hoon, Lee, Chan Uk, Jung, Young Kul, Seo, Yeon Seok, Yim, Hyung Joon, Yeon, Jong Eun, Byun, Kwan Soo

    ISSN: 0270-9139, 1527-3350, 1527-3350
    Vydavateľské údaje: United States Wolters Kluwer Health, Inc 01.09.2018
    Vydané v Hepatology (Baltimore, Md.) (01.09.2018)
    “…According to the American Association for the Study of Liver Diseases (AASLD) treatment guidelines for hepatocellular carcinoma (HCC), the role of surgery has…”
    Získať plný text
    Journal Article
  2. 2

    Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells Autor Lee, Young-Sun, Kim, So Yeon, Ko, Eunjung, Lee, Jun-Hee, Yi, Hyon-Seung, Yoo, Yang Jae, Je, Jihye, Suh, Sang Jun, Jung, Young Kul, Kim, Ji Hoon, Seo, Yeon Seok, Yim, Hyung Joon, Jeong, Won-Il, Yeon, Jong Eun, Um, Soon Ho, Byun, Kwan Soo

    ISSN: 2045-2322, 2045-2322
    Vydavateľské údaje: London Nature Publishing Group UK 16.06.2017
    Vydané v Scientific reports (16.06.2017)
    “…Non-alcoholic fatty liver disease (NAFLD) is a dominant cause of chronic liver disease, but the exact mechanism of progression from simple steatosis to…”
    Získať plný text
    Journal Article
  3. 3

    Diagnostic delay in inflammatory bowel disease increases the risk of intestinal surgery Autor Lee, Dong-Won, Koo, Ja Seol, Choe, Jung Wan, Suh, Sang Jun, Kim, Seung Young, Hyun, Jong Jin, Jung, Sung Woo, Jung, Young Kul, Yim, Hyung Joon, Lee, Sang Woo

    ISSN: 2219-2840, 2219-2840
    Vydavateľské údaje: United States 21.09.2017
    “…To investigate the factors affecting diagnostic delay and outcomes of diagnostic delay in inflammatory bowel disease (IBD). We retrospectively studied 165…”
    Zistit podrobnosti o prístupe
    Journal Article
  4. 4

    Renewed 2015 Clinical Practice Guidelines for Management of Hepatitis C by Korean Association for the Study of the Liver; What Has Been Changed? - Treatment of Chronic Hepatitis C Genotype 2 and 3 Autor Jung, Young Kul

    ISSN: 1598-9992, 2233-6869
    Vydavateľské údaje: Korea (South) 01.03.2016
    “…Ever since direct-acting antiviral agents (DAA) have been approved and released into the world, numerous studies on the efficacy, adverse effects and drug-drug…”
    Získať plný text
    Journal Article
  5. 5

    Predictability of clinical outcomes after external beam radiotherapy for hepatocellular carcinoma according to tumor marker dynamics Autor Park, Sunmin, Rim, Chai Hong, Jung, Young Kul, Yim, Hyung Joon, Chung, Hwan Hoon, Yoon, Won Sup

    ISSN: 1932-6203, 1932-6203
    Vydavateľské údaje: United States Public Library of Science 20.05.2025
    Vydané v PloS one (20.05.2025)
    “…Signal changes after high dose irradiation on MRI make it difficult to assess the therapeutic response of hepatocellular carcinoma (HCC). To overcome the…”
    Získať plný text
    Journal Article
  6. 6

    Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease Autor Kim, Tae Hyung, Lee, Yoonseok, Lee, Young-Sun, Gim, Jeong-An, Ko, Eunjung, Yim, Sun Young, Jung, Young Kul, Kang, SeongHee, Kim, Moon Young, Kim, Hayeon, Kim, Baek-hui, Kim, Ji Hoon, Seo, Yeon Seok, Yim, Hyung Joon, Yeon, Jong Eun, Um, Soon Ho, Byun, Kwan Soo

    ISSN: 2045-2322, 2045-2322
    Vydavateľské údaje: London Nature Publishing Group UK 19.07.2021
    Vydané v Scientific reports (19.07.2021)
    “…Nonalcoholic steatohepatitis (NASH) is considered as a progressive form of nonalcoholic fatty liver disease (NAFLD). To distinguish NASH from nonalcoholic…”
    Získať plný text
    Journal Article
  7. 7

    Regression of liver fibrosis and hepatocellular carcinoma development after HCV eradication with oral antiviral agents Autor Yoo, Hae Won, Park, Jun Yong, Kim, Sang Gyune, Jung, Young Kul, Lee, Sae Hwan, Kim, Moon Young, Jun, Dae Won, Jang, Jae Young, Lee, Jin Woo, Kwon, Oh Sang

    ISSN: 2045-2322, 2045-2322
    Vydavateľské údaje: London Springer Science and Business Media LLC 07.01.2022
    Vydané v Scientific Reports (07.01.2022)
    “…We prospectively investigated the changes of liver stiffness (LS) and the occurrence of hepatocellular carcinoma (HCC) after hepatitis C virus (HCV)…”
    Získať plný text
    Journal Article
  8. 8

    Accelerated muscle mass estimation from CT images through transfer learning Autor Yoon, Seunghan, Kim, Tae Hyung, Jung, Young Kul, Kim, Younghoon

    ISSN: 1471-2342, 1471-2342
    Vydavateľské údaje: London BioMed Central 09.10.2024
    Vydané v BMC medical imaging (09.10.2024)
    “…Background The cost of labeling to collect training data sets using deep learning is especially high in medical applications compared to other fields…”
    Získať plný text
    Journal Article
  9. 9

    Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis Autor Gu, Dae Hoe, Kim, Moon Young, Seo, Yeon Seok, Kim, Sang Gyune, Lee, Han Ah, Kim, Tae Hyung, Jung, Young Kul, Kandemir, Altay, Kim, Ji Hoon, An, Hyunggin, Yim, Hyung Joon, Yeon, Jong Eun, Byun, Kwan Soo, Um, Soon Ho

    ISSN: 2287-2728, 2287-285X, 2287-285X
    Vydavateľské údaje: Korea (South) Korean Association for the Study of the Liver 01.09.2018
    Vydané v Clinical and molecular hepatology (01.09.2018)
    “…The most widely used method for diagnosing sarcopenia is the skeletal muscle index (SMI). Several studies have suggested that psoas muscle thickness per height…”
    Získať plný text
    Journal Article
  10. 10

    Effect of Probiotics in Stress-Associated Constipation Model in Zebrafish (Danio rerio) Larvae Autor Lee, Ayoung, Kim, Seung Young, Kang, Seyoung, Kang, Seong Hee, Kim, Dong Woo, Choe, Jung Wan, Hyun, Jong Jin, Jung, Sung Woo, Jung, Young Kul, Koo, Ja Seol, Yim, Hyung Joon, Kim, Suhyun

    ISSN: 1422-0067, 1661-6596, 1422-0067
    Vydavateľské údaje: Switzerland MDPI AG 01.04.2024
    “…The pathophysiology of functional bowel disorders is complex, involving disruptions in gut motility, visceral hypersensitivity, gut–brain–microbiota…”
    Získať plný text
    Journal Article
  11. 11
  12. 12
  13. 13

    Therapeutic Decision Making in Hepatocellular Carcinoma According to Age and Child–Pugh Class: A Nationwide Cohort Analysis in South Korea Autor Park, Sunmin, Rim, Chai Hong, Jung, Young Kul, Yoon, Won Sup

    ISSN: 2291-2789, 2291-2797, 2291-2797
    Vydavateľské údaje: Egypt Hindawi 2021
    “…Background. We sought to analyze the preferred treatment modality by age and liver function in South Korea. Methods. The Korean Liver Cancer Study Group…”
    Získať plný text
    Journal Article
  14. 14

    Natural killer cell activity is a risk factor for the recurrence risk after curative treatment of hepatocellular carcinoma Autor Lee, Han Ah, Goh, Hyun Gil, Lee, Young-Sun, Jung, Young Kul, Kim, Ji Hoon, Yim, Hyung Joon, Lee, Min-Goo, An, Hyunggin, Jeen, Yoon Tae, Yeon, Jong Eun, Byun, Kwan Soo, Seo, Yeon Seok

    ISSN: 1471-230X, 1471-230X
    Vydavateľské údaje: London BioMed Central 12.06.2021
    Vydané v BMC gastroenterology (12.06.2021)
    “…Background Natural killer (NK) cells have been known to contribute to surveillance and control of hepatocellular carcinoma (HCC). However, the association of…”
    Získať plný text
    Journal Article
  15. 15

    Correspondence on Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis” Autor Kim, Tae Hyung, Jung, Young Kul, Yim, Hyung Joon

    ISSN: 2287-2728, 2287-285X, 2287-285X
    Vydavateľské údaje: Korea (South) Korean Association for the Study of the Liver 01.01.2023
    Vydané v Clinical and molecular hepatology (01.01.2023)
    “…In our study, change in muscle mass (ΔSMI)/yr%, which represented the change in muscle mass, was not an absolute value but a rate value divided by the muscle…”
    Získať plný text
    Journal Article
  16. 16

    Direct Bilirubin Is More Valuable than Total Bilirubin for Predicting Prognosis in Patients with Liver Cirrhosis Autor Lee, Han Ah, Jung, Joon Young, Lee, Young-Sun, Jung, Young Kul, Kim, Ji Hoon, An, Hyonggin, Yim, Hyung Joon, Jeen, Yoon Tae, Yeon, Jong Eun, Byun, Kwan Soo, Um, Soon Ho, Seo, Yeon Seok

    ISSN: 1976-2283, 2005-1212, 2005-1212
    Vydavateľské údaje: Editorial Office of Gut and Liver 01.07.2021
    Vydané v Gut and liver (01.07.2021)
    “…Most prognostic prediction models for patients with liver cirrhosis include serum total bilirubin (TB) level as a component. This study investigated prognostic…”
    Získať plný text
    Journal Article
  17. 17

    Adversarial Attacks on Medical Segmentation Model via Transformation of Feature Statistics Autor Lee, Woonghee, Ju, Mingeon, Sim, Yura, Jung, Young Kul, Kim, Tae Hyung, Kim, Younghoon

    ISSN: 2076-3417, 2076-3417
    Vydavateľské údaje: Basel MDPI AG 01.03.2024
    Vydané v Applied sciences (01.03.2024)
    “…Deep learning-based segmentation models have made a profound impact on medical procedures, with U-Net based computed tomography (CT) segmentation models…”
    Získať plný text
    Journal Article
  18. 18

    Hyponatremia in Liver Cirrhosis Autor Jang, Cheolmin, Jung, Young Kul

    ISSN: 1598-9992, 2233-6869, 2233-6869
    Vydavateľské údaje: Korea (South) 25.08.2018
    “…Hyponatremia is a commonly observed complication that is related to hypoalbuminemia and portal hypertension in patients with advanced liver cirrhosis…”
    Získať plný text
    Journal Article
  19. 19

    Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Autor Ahn, Young Eun, Suh, Sang Jun, Yim, Hyung Joon, Seo, Yeon Seok, Yoon, Eileen L., Kim, Tae Hyung, Lee, Young Sun, Yim, Sun Young, Kim, Hae Rim, Kang, Seong Hee, Jung, Young Kul, Kim, Ji Hoon, Yeon, Jong Eun, Um, Soon Ho, Byun, Kwan Soo

    ISSN: 1976-2283, 2005-1212, 2005-1212
    Vydavateľské údaje: Korea (South) Editorial Office of Gut and Liver 15.03.2021
    Vydané v Gut and liver (15.03.2021)
    “…Sorafenib is the first approved systemic treatment for advanced hepatocellular carcinoma (HCC). However, its clinical utility is limited, especially in Asian…”
    Získať plný text
    Journal Article
  20. 20